TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
12 hedge funds and large institutions have $722K invested in Titan Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-4
Holders Change %
-25%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
4
Closed
5
Calls
$58K
Puts
$36K
Net Calls
+$22K
Net Calls Change
+$176K
Top Buyers
1 |
Renaissance Technologies
New York
|
+$24K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.45K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.72K |
Top Sellers
1 |
Citadel Advisors
Miami,
Florida
|
-$179K |
2 |
Morgan Stanley
New York
|
-$128K |
3 |
VF
Virtu Financial
New York
|
-$87K |
4 |
Bank of New York Mellon
New York
|
-$40K |
5 |
![]()
Group One Trading
Chicago,
Illinois
|
-$27.1K |